TruAlt Bioenergy Ltd Q2 FY26 Earnings Analysis

Published 16 Aug 2026 | Market Cap: ₹4.0K Cr

Price

₹482

Market Cap

₹4.0K Cr

P/E Ratio

25.3

Earnings Summary

FY26 ethanol volume target revised to 36-37 crore liters (previously 41 crore liters). TruAlt Bioenergy expects a strong growth trajectory aligned with past performance trends, driven by diversified verticals: ethanol, CBG, retail fuel, and upcoming SAF segment.

📊 Revenue & Sales Performance

→FY26 ethanol volume target revised to 36-37 crore liters (previously 41 crore liters).
→H1 FY26 ethanol volume was 5.7 crore liters; expecting 31-32 crore liters in H2 FY26.
→Q3 and Q4 FY26 expected to contribute around 26-28 crore liters of ethanol production.
→Ethanol expected to remain primary revenue driver in next financial year, contributing ~85% of gross revenue; CBG (Compressed Biogas) to account for ~15%.
→Multiple feedstock integration (syrup, maize, rice, damaged food grains) enables year-round ethanol production beyond sugarcane season.
→CBG vertical expanding with 16-17 plants planned over next 9-12 months; current EBITDA margins 60-65%.
→SAF (Sustainable Aviation Fuel) plant commercial production expects commissioning by Aug-Sep 2027; revenue from FY28.
→Retail fuel franchise network rapidly expanding with 73 locations identified, supporting flex-fuel vehicle rollout.
→Overall, company anticipates strong volume ramp-up and revenue growth with portfolio diversification and improved capacity utilization.

📈 Profitability & Margins

→TruAlt Bioenergy expects a strong growth trajectory aligned with past performance trends, driven by diversified verticals: ethanol, CBG, retail fuel, and upcoming SAF segment.
→CBG segment shows robust growth with EBITDA margins around 60-68%, contributing significantly to profitability; PAT margin improved to nearly 50% in Q2 FY26.
→Ethanol volumes targeted at 36-37 crores liters for FY26, with an expected ramp-up in second half; EBITDA margins estimated at 15-16%.
→New SAF plant commissioning planned for FY28, expected to add to revenue and profitability thereafter.
→IRR for upcoming projects expected around 19-22%, with PAT margins growing to 30%+ as scale increases.
→Strategic plant expansions and multi-feed integrations will improve capacity utilization and operational efficiencies.
→Overall, the company anticipates multi-vertical growth leading to consistent value creation and improved EPS over time.

🏗️ Capital Expenditure Plans

- TruAlt Bioenergy has an MOU signed with Andhra Pradesh government for a project estimated at INR 2,250 crores. - Planned funding mix is approximately 30% equity and 70% debt, with potential for strategic partners and innovative financing models. - The project IRR is expected around 19% with a payback period of 3.5 to 4 years, assuming 85%-90% capacity utilization. - Expansion includes setting up 16-17 additional CBG plants within 9-12 months, boosting EBITDA margins to 60%-65%. - A Sustainable Aviation Fuel (SAF) plant is under technology transfer with Honeywell UOP, targeting commissioning around August-September 2027, with revenue beginning FY 2028. - Recent capital investments include a multi-feed plant addition and conversion to bagasse-based power systems to reduce costs. Overall, there is strong ongoing and planned capital investment focused on scaling ethanol, CBG, and SAF capacities.

💰 Fundraising & Capital Structure

→For the INR 2,200-2,250 crore MOU project with Andhra Pradesh government, TruAlt Bioenergy plans a 30:70 debt-to-equity funding mix.
→The company intends to bring in large strategic partners for this investment.
→The 30:70 debt-to-equity ratio is preliminary and subject to change; innovative financing models might be considered.
→The company has availed term loans from banks (financial liabilities increased from INR 996.23 crores to INR 1075.36 crores as of Sept 2025).
→Recent equity infusion occurred through IPO, anchor investors, and QIP retail, increasing equity from INR 582 crores to INR 1401.52 crores by Sept 2025.
→No explicit mention of fresh fundraising plans beyond these points in the provided transcript.

📋 Order Book & Pipeline

→TruAlt Bioenergy has a targeted ethanol supply order book of approximately 47 crore liters for the ethanol supply year Nov 2025–Oct 2026.
→Out of this, about 34 crore liters are allocated from government OMCs, and around 5.8 crore liters from private OMCs (Jio and Nayara combined).
→For FY25, the company supplied about 26.57 crore liters of ethanol.
→There is a pending/disputed allocation of 14 crore liters from the last ethanol year.
→The volume target for FY26 has been revised to 36–37 crore liters (down from an earlier 41 crore liters).
→Quarterly volumes in H1 FY26 were around 5.7 crore liters, with an expected ramp-up to 26–28 crore liters in Q3 and Q4 combined.

Key Metrics

Frequently Asked Questions

What were TruAlt Bioenergy Ltd Q2 FY26 results?

What is TruAlt Bioenergy Ltd share price analysis?

TruAlt Bioenergy Ltd currently shows a neutral. The stock trades at a P/E of 25.3 with a market cap of ₹3,958 Cr. Investors should review the full earnings analysis for detailed insights.

Is TruAlt Bioenergy Ltd planning capital expenditure?

TruAlt Bioenergy has an MOU signed with Andhra Pradesh government for a project estimated at INR 2,250 crores.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.